Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice
出版年份 2018 全文链接
标题
Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-05-30
DOI
10.1038/s41598-018-26904-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study
- (2018) Xavier Sáez-Llorens et al. LANCET INFECTIOUS DISEASES
- A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
- (2018) Viswanathan Ramasamy et al. PLoS Neglected Tropical Diseases
- Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
- (2018) Rahul Shukla et al. Frontiers in Microbiology
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Immune correlates of protection for dengue: State of the art and research agenda
- (2017) Leah C. Katzelnick et al. VACCINE
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?
- (2017) Stephen S. Whitehead et al. Cold Spring Harbor Perspectives in Biology
- In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
- (2017) Stephen S. Whitehead et al. PLoS Neglected Tropical Diseases
- DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection
- (2017) Jose L. Slon Campos et al. PLoS One
- Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies
- (2016) Niyati Khetarpal et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
- (2016) Ankur Poddar et al. BMC BIOTECHNOLOGY
- Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort
- (2016) Leah C. Katzelnick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
- (2016) Neil M. Ferguson et al. SCIENCE
- Protective and immunological behavior of chimeric yellow fever dengue vaccine
- (2016) Scott B. Halstead et al. VACCINE
- Immune correlates for dengue vaccine development
- (2015) Anon Srikiatkhachorn et al. Expert Review of Vaccines
- Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site
- (2015) Scott A. Smith et al. JOURNAL OF VIROLOGY
- Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice
- (2015) Satoru Watanabe et al. JOURNAL OF VIROLOGY
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells
- (2015) Amporn Suphatrakul et al. VACCINE
- Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
- (2015) Lav Tripathi et al. Frontiers in Microbiology
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Functional Analysis of Antibodies against Dengue Virus Type 4 Reveals Strain-Dependent Epitope Exposure That Impacts Neutralization and Protection
- (2013) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- The Economic Burden of Dengue
- (2012) Duane J. Gubler AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Evaluation of Extracellular Subviral Particles of Dengue Virus Type 2 and Japanese Encephalitis Virus Produced by Spodoptera frugiperda Cells for Use as Vaccine and Diagnostic Antigens
- (2010) M. Kuwahara et al. Clinical and Vaccine Immunology
- Dengue vaccines: state of the art
- (2010) Sathyamangalam Swaminathan et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris
- (2010) Gaurav Batra et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
- (2010) James D. Brien et al. JOURNAL OF VIROLOGY
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- Immature Dengue Virus: A Veiled Pathogen?
- (2010) Izabela A. Rodenhuis-Zybert et al. PLoS Pathogens
- Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
- (2010) Wahala M. P. B. Wahala et al. PLoS Pathogens
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
- (2010) Bimmi Shrestha et al. PLoS Pathogens
- Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native prM and E Proteins
- (2009) Pei-Gang Wang et al. PLoS One
- Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties
- (2009) Wenquan Liu et al. VIRUS GENES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now